The Veterinary Medicines Regulations 2013
- 4Placing a veterinary medicinal product on the market
- 5Manufacture of veterinary medicinal products
- 6Marketing of products not in accordance with a marketing authorisation
- 7Classification, supply and possession of the product
- 8Administration of the product
- 9Importation of authorised veterinary medicinal products
- 10Advertising the product
- 10aInducements and hospitality
- 11Advertising of prescription products and products containing psychotropic drugs or narcotics
- 12Defence of publication in the course of business
- 13Wholesale dealing
- 14Feedingstuffs
- 15Exemptions
- 16Fees
- 17Food-producing animals: proof of purchase of veterinary medicinal products
- 18Food-producing animals: records of administration by a veterinary surgeon
- 19Food-producing animals: records of acquisition and administration
- 20Food-producing animals: retention of records
- 21Records by a holder of a manufacturing authorisation
- 22Records by a holder of a wholesale dealer’s authorisation
- 23Records of the receipt or supply of prescription products
- 24Records of products administered to a food-producing animal under the cascade
- 24aReporting of sales and usage data in relation to antibiotics
- 28The Veterinary Products Committee
- 29Veterinary Products Committee appeals procedure
- 30Appeals to an appointed person
- 31Exports
- 32Time limits
- 33Appointment of inspectors
- 34Powers of entry
- 35Powers of an inspector
- 36Inspection of pharmacies
- 37Obstruction
- 38Improvement notices
- 39Appeals against improvement notices
- 40Powers of a court on appeal
- 41Seizure notices
- 42Publication
- 43Offence
- 44Penalties
- 45Northern Ireland
- 46Review
- 47Revocations
1 Application for a marketing authorisation
- 1Application for a marketing authorisation
- 2Information with the application: general
- 2aInformation with the application: format
- 2bInformation with the application: animal testing
- 2cInformation with the application: POM-VPS, NFA-VPS and AVM-GSL
- 3Summary of product characteristics
- 4Supply of a copy of the summary of product characteristics
- 5Time limits for applications for products for use in food-producing animals
2 Derogations from some of the requirements in Part 1
- 6Scope
- 7Bibliographic application
- 8Application for a product using a new combination of active substances
- 9Application using existing data
- 10Application for a generic veterinary medicinal product
- 10aHybrid veterinary medicinal products
- 11Time limits for marketing authorisations granted under the procedure for a generic veterinary medicinal pro
- 12Extension of time limits
- 12aTime limits – supplementary
- 13Parallel imports
- 14Specific batch control scheme
- 15Similar immunological products
- 16Marketing a product authorised in another country
3 Grant of a marketing authorisation
- 17Time limits
- 18Place of establishment of applicant
- 19Procedure
- 20Products authorised in another member State
- 21Assessment reports
- 22Grant of a marketing authorisation
- 22aWithdrawal of application for marketing authorisation
- 23Marketing authorisations for food-producing species
- 24Refusal of a marketing authorisation
- 25Publication following the grant , refusal, suspension, variation or revocation of a marketing authorisation
- 26Marketing authorisations in exceptional circumstances
- 27Provisions of samples and expertise
- 28Records and supply of information
- 29Duties on the holder of a marketing authorisation relating to an immunological product
- 30Control tests
- 31Placing on the market
- 32Duration and validity of marketing authorisation
4 Variations of marketing authorisations on the application of the holder
5 Suspension, etc. of a marketing authorisation
6 Mutual recognition and multiple applications
7 Labelling and package leaflets
- 45Approval by the Secretary of State
- 46Reference to being authorised
- 47Language
- 48Labelling of immediate packaging of veterinary medicinal products
- 49Labelling of the outer packaging of veterinary medicinal products
- 50Labelling of small immediate packaging units of veterinary medicinal products
- 51Package leaflet of veterinary medicinal products
- 52Small containers other than ampoules
- 53Homeopathic remedies
- 54Variations
- 55Qualified persons responsible for pharmacovigilance
- 56Duties of marketing authorisation holder in relation to pharmacovigilance
- 56aDuties of marketing authorisation holder in relation to signal management process
- 56bDuties of qualified person (pharmacovigilance)
- 56cSignal management process
- 57Adverse events following administration of a veterinary medicinal product
- 58Adverse reactions to a veterinary medicinal product administered in another country
- 59Annual benefit-risk reports
- 60Release of information by the marketing authorisation holder
- 60aPharmacovigilance inspections by Secretary of State
- 60bPowers of Secretary of State in relation to signal management process
- 61Action taken on account of pharmacovigilance
1 Manufacturing authorisations
- 1Manufacturing authorisation
- 2Application for authorisation
- 3Procedure for grant of authorisations and time limits
- 4The authorisation
- 4aApplication for variation to the authorisation
- 5Suspension, revocation etc of the authorisation
- 6Good manufacturing practice certificates and inspection of sites
- 7Report following inspection
- 8Duties on the holder of a manufacturing authorisation
- 8aGood manufacturing practice
- 8bRecalled and counterfeit products
- 9Qualified persons for manufacture
- 10Refusal, revocation, suspension or variation of appointment
- 11Duties on a qualified person
- 12Register
- 13Test sites
- 14Authorisation to manufacture specific veterinary medicinal products
- 15Prohibition
- 16Personnel
- 17Process of authorisation
- 18Authorisation in relation to blood banks
- 19Authorisation in relation to stem cells
- 20Authorisation in relation to products for administration under the cascade
- 21Suspension, compulsory variation or revocation of authorisation
- 22Labelling
- 23Records
- 24Adverse events
- 25Inspection of sites
3 Authorisation of blood banks
4 Authorisation of manufacturers of products for administration under the cascade
1 Classification and supply of authorised veterinary medicinal products
- 1Classification of veterinary medicinal products
- 2Wholesale supply of veterinary medicinal products
- 3Retail supply of veterinary medicinal products
- 3aSupply of samples
- 3bRegister of online suppliers of veterinary medicinal products
- 3cApplication for registration
- 3dDuties in relation to online supply
- 3eRetail storage of veterinary medicinal products
- 4Prescriptions by a veterinary surgeon
- 5Prescriptions
- 6Written prescriptions
- 7Duties when a product is prescribed or supplied
- 7aDuties in relation to prescribing of antibiotic veterinary medicinal products
- 8Supply by a veterinary surgeon from registered premises
- 9Supply by a veterinary surgeon
- 10Supply by a pharmacist
- 11Supply of a medicinal premix
- 12Labelling at the time of retail supply
- 13Supply of veterinary medicinal products for use under the cascade
- 14Supply by a suitably qualified person
- 15Audit
2 Requirements for a wholesale dealer’s authorisation
- 16Wholesale dealer’s authorisation
- 17Application for authorisation
- 18Procedure and time limits for authorisations
- 19Periodic inspections and suspension etc. for lack of use
- 19aApplication for variation to the authorisation
- 20Suspension, variation or revocation of the authorisation
- 21Duties on the holder of a wholesale dealer’s authorisation
- 21aRegister of authorised wholesale dealers
- 21bDocumentation accompanying veterinary medicinal products supplied wholesale
- 21cRecalled, counterfeit or returned products
- 21dAudit
- 21eContractual arrangements between holders of wholesale dealer’s authorisations
- 21fSelf-inspection programme
- 1Administration under the cascade
- 2Withdrawal periods
- 3Administration to food-producing horses
- 4Immunological products for serious epizootic disease or emerging disease
- 5Immunological products for an imported or exported animal
- 6Administration by veterinary surgeons from other countries
- 6aAdministration of autogenous vaccines
- 7Treatment in exceptional circumstances
- 8Administration of a homeopathic remedy
- 9Administration under an animal test certificate
- 9aMisuse of the cascade
- 10Offences
- 1Scope and interpretation
- 2Enforcement of Regulation (EC) No 178/2002
- 3Enforcement of Regulation (EC) No 1831/2003
- 4Enforcement of Regulation (EU) 2017/625
- 5Enforcement of Regulation (EC) No 183/2005
- 6Enforcement of Regulation (EC) No 767/2009
- 7Authorisation of manufacturers and distributors of feedingstuffs containing medicinal premixes
- 8Incorporation of a medicinal premix into an intermediate feedingstuff
- 9Top dressing
- 10Incorporation of a medicinal premix into feedingstuffs
- 11Additional record keeping requirements relating to medicinal premixes
- 12Labelling an intermediate feedingstuff containing a medicinal premix
- 13Labelling of feedingstuffs containing a specified feed additive
- 14Labelling of feedingstuffs containing a medicinal premix
- 15Supply of specified feed additives
- 16Supply of intermediate feedingstuff or specified feed additive
- 17Supply of a complementary feedingstuff
- 18Supply of feedingstuffs containing a medicinal premix
- 19Medicated feedingstuff prescriptions for feedingstuffs containing a medicinal premix
- 20Writing the medicated feedingstuff prescription
- 21Possession
- 22Sampling and analysis
- 22aSampling for cross-contamination
- 23Storage
- 24Packages and other containers
- 25Transport
- 26Possession, placing on the market and use of feedingstuffs
- 26aUnused and expired medicated feedingstuffs
- 27Imports from third countries
- 28Trade between countries
- 29Import for incorporation into intermediate feedingstuffs or feedingstuffs for export
- 30Animals on domestic premises
- 31Offences
- 1Animals to which this Schedule applies
- 2Placing on the market, importing and administering the product
- 3Manufacture
- 3aRegister of persons placing veterinary medicinal products on the market (small pet animals)
- 3bPersons registered in accordance with paragraph 3A: annual return
- 4Approval of the active substance
- 5The product
- 6Labelling
- 7Administration
- 8Pack size
- 9Adverse events
- 10Offences
2 Fees relating to marketing authorisations
- 7Application for a marketing authorisation for a pharmaceutical , immunological or biological that is not imm
- 7aApplication for a marketing authorisation for specific applications
- 8Decentralised pharmaceutical application where the United Kingdom is the reference member State
- 9Application for a marketing authorisation for an immunological or biosimilar product
- 10Decentralised immunological application where the United Kingdom is the reference member State
- 11Application for a marketing authorisation based on informed consent
- 12Application for an exceptional marketing authorisation (pharmaceutical)
- 13Fees for an application for an exceptional marketing authorisation (immunological or biological non-immunol
- 14Fee for the conversion from an exceptional to a full marketing authorisation
- 15Application for a marketing authorisation relating to a parallel import
- 15aFee for a generic marketing authorisation
- 16Application to change the distribution category of a product authorised through the centralised procedure
- 17Application for a variation to a marketing authorisation …
- 18Application for a variation to a marketing authorisation dealt with under worksharing procedures
- 19Application for an extension dealt with under the decentralised procedure where the United Kingdom is the r
- 20Provision of information relating to the recognition of a United Kingdom marketing authorisation or an exte
- 21Exception for a variation relating to animal testing
- 22Application for a reassessment of an exceptional marketing authorisation
- 23Application for the renewal of a marketing authorisation obtained through mutual recognition or the decentr
- 24Registration of a homeopathic remedy
- 25Renewal of a homeopathic remedy
- 26Annual fees for marketing authorisations
- 27Auditor’s certificate
3 Fees payable by manufacturers
- 28Application for a manufacturing authorisation
- 29Application for a variation of a manufacturing authorisation
- 30Inspection of sites authorised to manufacture a product for administration under the cascade
- 30aAutogenous vaccines
- 30bAssessment of a variation of an authorisation to manufacture an autogenous vaccine
- 31Annual fee (manufacturing authorisations)
- 32Site inspections – type of site
- 33Inspection of a site where immunological veterinary medicinal products are manufactured
- 34Inspection of a site where sterile veterinary medicinal products are manufactured
- 35Inspection of a site where no immunological or sterile veterinary medicinal products are manufactured
- 36Inspection of a site where veterinary medicinal products are assembled
- 37Test sites
- 38Animal blood bank or non-food animal stem cell centre authorisations
4 Fees relating to a wholesale dealer’s authorisation
5 Fees relating to feedingstuffs
- 47Testing samples
- 48Animal test certificates
- 49Importation of a veterinary medicinal product for treatment under the cascade
- 50Wholesale dealer’s import certificate
- 51Specific batch control
- 52Submission of control tests of an immunological product
- 53Export certificates
- 54Provision of advice
- 54aProvision of scientific advice
- 55Appeals to the Veterinary Products Committee
- 56Fee relating to an appointed person
- 57Fees relating to a veterinary … practice premises
- 57aFee in relation to verifying destruction of controlled drug
- 57bPharmacovigilance inspections
- 58Refund of fees relating to the Veterinary Products Committee or appointed persons
- 59Fees relating to an improvement notice
- 60Non-payment of fees
- 61Waiver or reduction of fees
- 62Reduction of fees when an application is withdrawn
Source: legislation.gov.uk (The National Archives), UK legislation with its point-in-time versions. Official publication. Reuse: Open Government Licence v3.0.